BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2922 related articles for article (PubMed ID: 21258394)

  • 1. Regulation of cancer cell metabolism.
    Cairns RA; Harris IS; Mak TW
    Nat Rev Cancer; 2011 Feb; 11(2):85-95. PubMed ID: 21258394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cancer metabolism: key players in metabolic reprogramming.
    Soga T
    Cancer Sci; 2013 Mar; 104(3):275-81. PubMed ID: 23279446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glutamine reliance in cell metabolism.
    Yoo HC; Yu YC; Sung Y; Han JM
    Exp Mol Med; 2020 Sep; 52(9):1496-1516. PubMed ID: 32943735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two decades of a protooncogene HPIP/PBXIP1: Uncovering the tale from germ cell to cancer.
    Khumukcham SS; Manavathi B
    Biochim Biophys Acta Rev Cancer; 2021 Aug; 1876(1):188576. PubMed ID: 34090932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Control of YAP/TAZ Activity by Metabolic and Nutrient-Sensing Pathways.
    Santinon G; Pocaterra A; Dupont S
    Trends Cell Biol; 2016 Apr; 26(4):289-299. PubMed ID: 26750334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis.
    Daye D; Wellen KE
    Semin Cell Dev Biol; 2012 Jun; 23(4):362-9. PubMed ID: 22349059
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STAT3, HIF-1, glucose addiction and Warburg effect.
    Darnell JE
    Aging (Albany NY); 2010 Dec; 2(12):890-1. PubMed ID: 21149895
    [No Abstract]   [Full Text] [Related]  

  • 8. Interplay between ROS and autophagy in cancer cells, from tumor initiation to cancer therapy.
    Poillet-Perez L; Despouy G; Delage-Mourroux R; Boyer-Guittaut M
    Redox Biol; 2015; 4():184-92. PubMed ID: 25590798
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Emerging Hallmarks of Cancer Metabolism.
    Pavlova NN; Thompson CB
    Cell Metab; 2016 Jan; 23(1):27-47. PubMed ID: 26771115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of transcription factors that may reprogram lung adenocarcinoma.
    Liu C; Zhang YH; Huang T; Cai Y
    Artif Intell Med; 2017 Nov; 83():52-57. PubMed ID: 28377053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations of metabolic genes and metabolites in cancer.
    Oermann EK; Wu J; Guan KL; Xiong Y
    Semin Cell Dev Biol; 2012 Jun; 23(4):370-80. PubMed ID: 22306135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between Hippo signalling and miRNAs in tumour progression.
    Li N; Xie C; Lu N
    FEBS J; 2017 Apr; 284(7):1045-1055. PubMed ID: 27973704
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CBP/p300 antagonises EGFR-Ras-Erk signalling and suppresses increased Ras-Erk signalling-induced tumour formation in mice.
    Ichise T; Yoshida N; Ichise H
    J Pathol; 2019 Sep; 249(1):39-51. PubMed ID: 30953353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ROS, autophagy, mitochondria and cancer: Ras, the hidden master?
    Bellot GL; Liu D; Pervaiz S
    Mitochondrion; 2013 May; 13(3):155-62. PubMed ID: 22750269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BCL9-2 promotes early stages of intestinal tumor progression.
    Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
    Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The redox regulation of thiol dependent signaling pathways in cancer.
    Giles GI
    Curr Pharm Des; 2006; 12(34):4427-43. PubMed ID: 17168752
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor LATS1 is a negative regulator of oncogene YAP.
    Hao Y; Chun A; Cheung K; Rashidi B; Yang X
    J Biol Chem; 2008 Feb; 283(9):5496-509. PubMed ID: 18158288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The consequences of enhanced cell-autonomous glucose metabolism.
    Locasale JW
    Trends Endocrinol Metab; 2012 Nov; 23(11):545-51. PubMed ID: 22920571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic profiling of cancer cells reveals genome-wide crosstalk between transcriptional regulators and metabolism.
    Ortmayr K; Dubuis S; Zampieri M
    Nat Commun; 2019 Apr; 10(1):1841. PubMed ID: 31015463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The chromatin remodeling BAP complex limits tumor-promoting activity of the Hippo pathway effector Yki to prevent neoplastic transformation in
    Song S; Herranz H; Cohen SM
    Dis Model Mech; 2017 Oct; 10(10):1201-1209. PubMed ID: 28754838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 147.